THCmax(a.k.a.TotalTHC)=d9-THC+(THC-A*0.877)CBDmax(a.k.a.TotalCBD)=CBD+(CBD-A*0.877)
TotalCannabinoidisarawsumofallmeasuredcannabinoidsInTraceability,TotalCannabinoidisasumofTHCmaxandCBDmax
Figuresmaydifferslightlyfromtraceabilityduetorounding
ND=NotDetectedNE=NotExamined
Unk=Unknown
AnalyticalMethodsUsedCannabinoids:HPLC-UVMicrobial:PlateCountingTerpenes:HS-GC-FIDSolvents:HS-GC-MS
TraceResidue:UHPLC-MSMS
WaterActivity:HYGROMER®Page1of4
OfficialTestResultsforLaboratorySample#6110613Origination: ZoneInCBD UBI#: Inventory#: 190120
Strain: ZoneInBalance License#: QA#: BC1107201900015Type: Capsule HarvestDate: Unknown Result#: Unlisted
Address: 6947CoalCreekPkwySE#199 Date ofReceipt: 2019-11-07 ApprovedBy: N.Mosely,CEOBellevue,WA98059 Date ofTesting: 2019-11-10 S.Stevens,LDR
DosageCalculation
NetWt THC CBD
Unit: 0.8g Unk 17mg/unit
Thesevaluescalculatedbythemanufacturer.
ChemicalProfile(unitsinmg/g)THCmax CBDmax BisaboloND
rawsum:ND23.5
rawsum:23.5 0.12
THCA ND d9-THC ND EudesmolCBDA 0.189 CBD 23.3
0.028CBGA ND CBG NDCBC 0.178 CBN ND GuaiolTHCVA ND THCV ND
0.027CBDVA NE CBDV 0.153CBT 0.296 d8-THC ND Terptotal:0.21
TotalCannabinoids(rawsum):24.1
ShelfStability
Loss-On-Drying NEWaterActivity: 0.4492
CannabinoidProfile(unitsinmg/g)100
10
1
0.1
0.01d9-THC
CBD CBG CBC CBN THCV d8-THC
CBDV CBT
ThesetestingresultsarecertifiedbyscientificexaminationofasinglesampleprovidedbytheProducer/Processor.ConfidenceAnalyticsanditsagentsdidnotobserveorparticipateinthesampleselectionprocess,andcannotconfirmtheauthenticityofthesampleoritsrepresentativenessoftheassociatedlot/batch.Thesample,asreceived,washomogenizedbeforesubsamples
weredrawnforspecificanalyses.Thisreportissupplementaltoanyotherreportswiththesameanalyticsamplenumber.
23.5
.178 .15
.296
THCmax(a.k.a.TotalTHC)=d9-THC+(THC-A*0.877)CBDmax(a.k.a.TotalCBD)=CBD+(CBD-A*0.877)
TotalCannabinoidisarawsumofallmeasuredcannabinoidsInTraceability,TotalCannabinoidisasumofTHCmaxandCBDmax
Figuresmaydifferslightlyfromtraceabilityduetorounding
ND=NotDetectedNE=NotExamined
Unk=Unknown
AnalyticalMethodsUsedCannabinoids:HPLC-UVMicrobial:PlateCountingTerpenes:HS-GC-FIDSolvents:HS-GC-MS
TraceResidue:UHPLC-MSMS
WaterActivity:HYGROMER®Page2of4
OfficialTestResultsforLaboratorySample#6110613Origination: ZoneInCBD UBI#: Inventory#: 190120
Strain: ZoneInBalance License#: QA#: BC1107201900015Type: Capsule HarvestDate: Unknown Result#: Unlisted
Address: 6947CoalCreekPkwySE#199 Date ofReceipt: 2019-11-07 ApprovedBy: N.Mosely,CEOBellevue,WA98059 Date ofTesting: 2019-11-10 S.Stevens,LDR
QuantitativeImpuritiesReport
Concentrationsofanalytesusedtodeterminepass/failstatusofindividualtests.
*Greaterthanlowerlimitofdetection(>LLOD)andlessthanlowerlimitofquantification(ULOQ).Appliestoinstanceswhentheanalyteconcentrationinthesampleisgreaterthanwecanaccuratelymeasurewithoutadditionaltesting.Numbershownisupperendofcalibration(ULOQ).
Findings
ALKANESAnalyte Concentration ActionLevelHexane <RL 290ppmCyclohexane <RL 3900ppmButane <RL 5000ppmPentane <RL 5000ppmHeptane <RL 5000ppmPropane <RL 5000ppm*ReportingLimit(RL)=10ppm
ALLOWEDINGREDIENTSAnalyte ConcentrationEthanol <RL*ReportingLimit(RL)=500ppm
IMPURITIESAnalytes Concentration ActionLevelAcetone <RL 5000ppmBenzene <RL 2ppmChloroform <RL 2ppmDichloromethane <RL 600ppmEthyl_Acetate <RL 5000ppmIsopropanol <RL 5000ppmXylene <RL 2200ppmMethanol <RL 3000ppmToluene <RL 890ppm*ReportingLimit(RL)=HalfActionLevel
MYCOTOXINSAnalyte Concentration ActionLevel*AflatoxinB1 <LLOQ 20ppbAflatoxinB2 <LLOQ 20ppbAflatoxinG1 <LLOQ 20ppbAflatoxinG2 <LLOQ 20ppbOchratoxinA <LLOQ 20ppb*ActionLevelisSumofAflatoxins
MICROBIOLOGICALSOrganism CFU/g ActionLevelBTGNBacteria 0 10000YeastandMold NE N/AE.coli 0 1Salmonella 0 1
ThesetestingresultsarecertifiedbyscientificexaminationofasinglesampleprovidedbytheProducer/Processor.ConfidenceAnalyticsanditsagentsdidnotobserveorparticipateinthesampleselectionprocess,andcannotconfirmtheauthenticityofthesampleoritsrepresentativenessoftheassociatedlot/batch.Thesample,asreceived,washomogenizedbeforesubsamples
weredrawnforspecificanalyses.Thisreportissupplementaltoanyotherreportswiththesameanalyticsamplenumber.
THCmax(a.k.a.TotalTHC)=d9-THC+(THC-A*0.877)CBDmax(a.k.a.TotalCBD)=CBD+(CBD-A*0.877)
TotalCannabinoidisarawsumofallmeasuredcannabinoidsInTraceability,TotalCannabinoidisasumofTHCmaxandCBDmax
Figuresmaydifferslightlyfromtraceabilityduetorounding
ND=NotDetectedNE=NotExamined
Unk=Unknown
AnalyticalMethodsUsedCannabinoids:HPLC-UVMicrobial:PlateCountingTerpenes:HS-GC-FIDSolvents:HS-GC-MS
TraceResidue:UHPLC-MSMS
WaterActivity:HYGROMER®Page3of4
OfficialTestResultsforLaboratorySample#6110613Origination: ZoneInCBD UBI#: Inventory#: 190120
Strain: ZoneInBalance License#: QA#: BC1107201900015Type: Capsule HarvestDate: Unknown Result#: Unlisted
Address: 6947CoalCreekPkwySE#199 Date ofReceipt: 2019-11-07 ApprovedBy: N.Mosely,CEOBellevue,WA98059 Date ofTesting: 2019-11-10 S.Stevens,LDR
ChemicalResidueScreen-TestReport
Cannabissampleswerehomogenizedandextractedusingacustomprotocol.InstrumentalanalysiswasperformedwithUHPLC-MS/MS(tandemquadrupole).TargetcompoundswereidentifiedbymatchingtoCertifiedReferenceMaterials.Ion-selectivedetection(multiplereactionmonitoring,orMRM)wasusedtoensurethatprecursorandproductionsofthecorrectmassesco-elutedandwereobservedinratiosmatchingthoseforthereferencematerials.
Dozensofcompoundsrepresentingmanydifferentclassesoffungicides,herbicides,andplantgrowthregulatorswerescreenedfor.ThisdocumentlistsallanalytesdetectedintheChemicalResidueScreen.
Findings
AnalyteName CAS#AmountInSample PASS/FAIL
WAStateActionLevel
(sum)Spinosads NA NOTDETECTED PASS 0.20ppm(sum)Permethrins NA NOTDETECTED PASS 0.20ppmAbamectinB1a 71751-41-2 NOTDETECTED PASS 0.50ppmAcephate 30560-19-1 NOTDETECTED PASS 0.40ppmAcetamiprid 135410-20-7 NOTDETECTED PASS 0.20ppmAldicarb 116-06-3 NOTDETECTED PASS 0.40ppmAzoxystrobin 131860-33-8 NOTDETECTED PASS 0.20ppmBifenazate 149877-41-8 NOTDETECTED PASS 0.20ppmBoscalid 188425-85-6 NOTDETECTED PASS 0.40ppmCarbaryl 63-25-2 NOTDETECTED PASS 0.20ppmCarbofuran 1563-66-2 NOTDETECTED PASS 0.20ppmChlorantraniliprole 500008-45-7 NOTDETECTED PASS 0.20ppmChlormequat 7003-89-6 NOTDETECTED PASS 0.10ppmcis-Permethrin 52645-53-1 NOTDETECTED PASS 0.20ppmClofentezine 74115-24-5 NOTDETECTED PASS 0.20ppmDaminozide 1596-84-5 NOTDETECTED PASS 1.00ppmDiazinon 333-41-5 NOTDETECTED PASS 0.20ppmDichlorvos 62-73-7 NOTDETECTED PASS 0.10ppm
AnalyteName CAS#AmountInSample PASS/FAIL
WAStateActionLevel
Dimethoate 60-51-5 NOTDETECTED PASS 0.20ppmEthoprophos 13194-48-4 NOTDETECTED PASS 0.20ppmEtofenprox 80844-07-1 NOTDETECTED PASS 0.40ppmEtoxazole 153233-91-1 NOTDETECTED PASS 0.20ppmFenoxycarb 72490-01-8 NOTDETECTED PASS 0.20ppmFenpyroximate 134098-61-6 NOTDETECTED PASS 0.40ppmFipronil 120068-37-3 NOTDETECTED PASS 0.40ppmFlonicamid 158062-67-0 NOTDETECTED PASS 1.00ppmFludioxonil 131341-86-1 NOTDETECTED PASS 0.40ppmHexythiazox 78587-05-0 NOTDETECTED PASS 1.00ppmImazalil 35554-44-0 NOTDETECTED PASS 0.20ppmImidacloprid 138261-41-3 NOTDETECTED PASS 0.40ppmKresoxim-methyl 143390-89-0 NOTDETECTED PASS 0.40ppmMalathion 121-75-5 NOTDETECTED PASS 0.20ppmMetalaxyl 57837-19-1 NOTDETECTED PASS 0.20ppmMethiocarb 2032-65-7 NOTDETECTED PASS 0.20ppmMethomyl 16752-77-5 NOTDETECTED PASS 0.40ppmMyclobutanil 88671-89-0 NOTDETECTED PASS 0.20ppm
*Greaterthanlowerlimitofdetection(>LLOD)andlessthanlowerlimitofquantification(ULOQ).Appliestoinstanceswhentheanalyteconcentrationinthesampleisgreaterthanwecanaccuratelymeasurewithoutadditionaltesting.Numbershownisupperendofcalibration(ULOQ).
ThesetestingresultsarecertifiedbyscientificexaminationofasinglesampleprovidedbytheProducer/Processor.ConfidenceAnalyticsanditsagentsdidnotobserveorparticipateinthesampleselectionprocess,andcannotconfirmtheauthenticityofthesampleoritsrepresentativenessoftheassociatedlot/batch.Thesample,asreceived,washomogenizedbeforesubsamples
weredrawnforspecificanalyses.Thisreportissupplementaltoanyotherreportswiththesameanalyticsamplenumber.
THCmax(a.k.a.TotalTHC)=d9-THC+(THC-A*0.877)CBDmax(a.k.a.TotalCBD)=CBD+(CBD-A*0.877)
TotalCannabinoidisarawsumofallmeasuredcannabinoidsInTraceability,TotalCannabinoidisasumofTHCmaxandCBDmax
Figuresmaydifferslightlyfromtraceabilityduetorounding
ND=NotDetectedNE=NotExamined
Unk=Unknown
AnalyticalMethodsUsedCannabinoids:HPLC-UVMicrobial:PlateCountingTerpenes:HS-GC-FIDSolvents:HS-GC-MS
TraceResidue:UHPLC-MSMS
WaterActivity:HYGROMER®Page4of4
OfficialTestResultsforLaboratorySample#6110613Origination: ZoneInCBD UBI#: Inventory#: 190120
Strain: ZoneInBalance License#: QA#: BC1107201900015Type: Capsule HarvestDate: Unknown Result#: Unlisted
Address: 6947CoalCreekPkwySE#199 Date ofReceipt: 2019-11-07 ApprovedBy: N.Mosely,CEOBellevue,WA98059 Date ofTesting: 2019-11-10 S.Stevens,LDR
ChemicalResidueScreen-TestReport
Cannabissampleswerehomogenizedandextractedusingacustomprotocol.InstrumentalanalysiswasperformedwithUHPLC-MS/MS(tandemquadrupole).TargetcompoundswereidentifiedbymatchingtoCertifiedReferenceMaterials.Ion-selectivedetection(multiplereactionmonitoring,orMRM)wasusedtoensurethatprecursorandproductionsofthecorrectmassesco-elutedandwereobservedinratiosmatchingthoseforthereferencematerials.
Dozensofcompoundsrepresentingmanydifferentclassesoffungicides,herbicides,andplantgrowthregulatorswerescreenedfor.ThisdocumentlistsallanalytesdetectedintheChemicalResidueScreen.
Findings
AnalyteName CAS#AmountInSample PASS/FAIL
WAStateActionLevel
Naled 300-76-5 NOTDETECTED PASS 0.50ppmOxamyl 23135-22-0 NOTDETECTED PASS 1.00ppmPaclobutrazol 76738-62-0 NOTDETECTED PASS 0.40ppmPhosemet(Imidan) 732-11-6 NOTDETECTED PASS 0.20ppmPiperonylButoxide 51-03-6 NOTDETECTED PASS 2.00ppmPrallethrin 23031-36-9 NOTDETECTED PASS 0.20ppmPropiconazole 60207-90-1 NOTDETECTED PASS 0.40ppmPropoxur 114-26-1 NOTDETECTED PASS 0.20ppmPyrethrinI 8003-34-7 NOTDETECTED PASS 1.00ppmPyridaben 96489-71-3 NOTDETECTED PASS 0.20ppmSpinosadA 168316-95-8 NOTDETECTED PASS 0.20ppmSpinosadD 168316-95-9 NOTDETECTED PASS 0.20ppmSpiromesifen 283594-90-1 NOTDETECTED PASS 0.20ppmSpirotetramat 203313-25-1 NOTDETECTED PASS 0.20ppmSpiroxamine 118134-30-8 NOTDETECTED PASS 0.40ppmTebuconazole 80443-41-0 NOTDETECTED PASS 0.40ppmThiacloprid 111988-49-9 NOTDETECTED PASS 0.20ppmThiamethoxam 153719-23-4 NOTDETECTED PASS 0.20ppm
AnalyteName CAS#AmountInSample PASS/FAIL
WAStateActionLevel
trans-Permethrin 52645-53-2 NOTDETECTED PASS 0.20ppmTrifloxystrobin 141517-21-7 NOTDETECTED PASS 0.20ppmUniconazole 83657-22-1 NOTDETECTED PASS 0.10ppm
*Greaterthanlowerlimitofdetection(>LLOD)andlessthanlowerlimitofquantification(ULOQ).Appliestoinstanceswhentheanalyteconcentrationinthesampleisgreaterthanwecanaccuratelymeasurewithoutadditionaltesting.Numbershownisupperendofcalibration(ULOQ).
ThesetestingresultsarecertifiedbyscientificexaminationofasinglesampleprovidedbytheProducer/Processor.ConfidenceAnalyticsanditsagentsdidnotobserveorparticipateinthesampleselectionprocess,andcannotconfirmtheauthenticityofthesampleoritsrepresentativenessoftheassociatedlot/batch.Thesample,asreceived,washomogenizedbeforesubsamples
weredrawnforspecificanalyses.Thisreportissupplementaltoanyotherreportswiththesameanalyticsamplenumber.
Medicine Creek Analytics Certificate of Analysis3700 Pacific HWY E, Ste 400, Fife, WA 98424 WA State I502 Certification 0018 | ISO 17025 91428 | Accreditation #91428
Sample 6110613
#COC/INVOICE: 171-20
Laboratory ID 191113-007 Matrix Edible
Licensee License 0003 Address 14797 NE 95th St, Redmond, WA, 98052 Name Confidence Analytics
Sampled - Received Nov 13, 2019 Reported Nov 22, 2019
Analyses executed MET
MET - Heavy Metals Detection AnalysisAnalyzed Nov 22, 2019 | Instrument ICP-MS
Analyte LODug/5gLOQ
ug/5gResultug/5g
WRL ug/5g Analyte
LODug/5g
LOQug/5g
Resultug/5g
WRL ug/5g
Arsenic (As) 0.02 0.06 ND 10 Cadmium (Cd) 0.01 0.04 ND 4.1Lead (Pb) 0.01 0.02 ND 6 Mercury (Hg) 0.02 0.07 ND 2
191113-007 page 1 of 1 R&D
NR Not ReportedND Not Detected